wrans/answers2025-03-14 conversation_150
Source: hansard.parliament.uk (2025-03-14)

UK Parliament Hansard data: wrans/answers2025-03-14 conversation_150

Helen Morgan:To ask the Secretary of State for Health and Social Care, if he will make an estimate of the number of pharmacies that have been registered in each integrated care board area for each year since financial year 2021-22. \p Stephen Kinnock: NHS England maintains the lists of National Health Service pharmacies in each Health and Wellbeing Board area. As high volumes of changes take place each month, the consolidated pharmaceutical list is produced and validated on a quarterly basis. Since the second quarter of 2022/23, the consolidated lists are published on the NHS Business Services Authority (NHSBSA) Open data portal, which is available at the following link:

https://opendata.nhsbsa.net/dataset/consolidated-pharmaceutical-list

The following table shows the number of community pharmacies included in the fourth quarter consolidated pharmaceutical list for each integrated care board (ICB) between 2021/22 and 2023/24:

ICB

31 March 2022

31 March 2023

31 March 2024

31 December 2024

Bath and North East Somerset, Swindon and Wiltshire ICB

146

148

138

138

Bedfordshire, Luton and Milton Keynes ICB

158

159

151

149

Birmingham and Solihull ICB

317

312

304

301

Black Country ICB

280

275

267

263

Bristol, North Somerset and South Gloucestershire ICB

167

167

156

156

Buckinghamshire, Oxfordshire and Berkshire West ICB

264

265

249

248

Cambridgeshire and Peterborough ICB

149

151

141

140

Cheshire and Merseyside ICB

585

578

542

540

Cornwall and the Isles of Scilly ICB

98

99

94

90

Coventry and Warwickshire ICB

196

194

184

181

Derby and Derbyshire ICB

209

206

198

197

Devon ICB

224

225

204

203

Dorset ICB

144

143

138

135

Frimley ICB

137

137

130

129

Gloucestershire ICB

110

110

105

105

Greater Manchester ICB

656

653

631

626

Hampshire and the Isle of Wight ICB

305

300

284

283

Herefordshire and Worcestershire ICB

122

121

118

116

Hertfordshire and West Essex ICB

286

286

269

266

Humber and North Yorkshire ICB

324

323

300

297

Kent and Medway ICB

325

323

308

305

Lancashire and South Cumbria ICB

395

390

368

367

Leicester, Leicestershire and Rutland ICB

228

227

222

222

Lincolnshire ICB

117

115

112

114

Mid and South Essex ICB

217

214

199

198

Norfolk and Waveney ICB

182

181

171

169

North Central London ICB

299

295

290

290

North East and North Cumbria ICB

651

648

614

613

North East London ICB

380

382

371

368

North West London ICB

502

500

477

475

Northamptonshire ICB

127

126

125

125

Nottingham and Nottinghamshire ICB

227

226

221

216

Shropshire and Telford and Wrekin ICB

83

83

82

79

Somerset ICB

101

100

91

91

South East London ICB

336

338

326

323

South West London ICB

292

293

278

272

South Yorkshire ICB

310

312

305

304

Staffordshire and Stoke on Trent ICB

240

238

233

232

Suffolk and North East Essex ICB

170

171

162

162

Surrey Heartlands ICB

176

175

162

160

Sussex ICB

310

311

291

290

West Yorkshire ICB

545

543

514

505

Source: NHSBSA

Note: The consolidated pharmaceutical list for the fourth quarter of 2024/25 will be published once the validation process is completed, so the third quarter data of 2024/25 has been provided instead.